Author:
Azizi Fereidoun,Amouzegar Atieh,Khalili Davood,Abdi Hengameh,Tohidi Maryam,Hedayati Mehdi,Cheraghi Leila,Mehrabi Yadollah,Takyar Miralireza
Funder
Shahid Beheshti University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. J.P. Brito, S. Payne, N. Singh Ospina, R. Rodriguez-Gutierrez, S. Maraka, L.R. Sangaralingham, N.M. Iñiguez-Ariza, V.M. Montori, M.N. Stan, Patterns of use, efficacy, and safety of treatment options for patients with Graves’ disease: a nationwide population-based study. Thyroid 30(3), 357–364 (2020)
2. C.M. van Kinschot, V.R. Soekhai, E.W. de Bekker-Grob, W.E. Visser, R.P. Peeters, T.M. van Ginhoven, C. van Noord, Preferences of patients and clinicians for treatment of Graves’ disease: a discrete choice experiment. Eur. J. Endocrinol. 184(6), 803–812 (2021)
3. F. Azizi, R. Malboosbaf, Long-term antithyroid drug treatment: a systematic review and meta-analysis. Thyroid 27(10), 1223–1231 (2017)
4. F. Azizi, V. Yousefi, A. Bahrainian, F. Sheikholeslami, M. Tohidi, Y. Mehrabi, Long-term continuous methimazole or radioiodine treatment for hyperthyroidism. Arch. Iran. Med. 15(8), 0–0 (2012)
5. O.M. El Kawkgi, D.S. Ross, M.N. Stan, Comparison of long‐term antithyroid drugs versus radioactive iodine or surgery for Graves’ disease: a review of the literature. Clin. Endocrinol. 95(1), 3–12 (2021)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献